Pathios Therapeutics
Pre-clinicalPioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Founded
2017
Focus
Small Molecules
About
Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Funding History
2Total raised: $85M
Series B$60MForbionOct 15, 2023
Series A$25MLifearcOct 15, 2021
Company Info
TypePrivate
Founded2017
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile